|
Gilbert Cisneros
|
house |
alexion Pharmaceuticals, Inc. (aLXN) |
ALXN |
STOCK |
Purchase
|
Feb. 24, 2020 |
$$1,001 - $15,000 |
March 10, 2020 |
|
Gilbert Cisneros
|
house |
alexion Pharmaceuticals, Inc. (aLXN) |
ALXN |
STOCK |
Sale (partial)
|
Feb. 7, 2020 |
$$1,001 - $15,000 |
March 10, 2020 |
|
Gilbert Cisneros
|
house |
alexion Pharmaceuticals, Inc. P |
ALXN |
STOCK |
Sale
|
Aug. 14, 2019 |
$$1,001 - $15,000 |
Sept. 11, 2019 |
|
Nicholas Van Taylor
|
house |
alexion Pharmaceuticals, Inc. (aLXN) |
ALXN |
STOCK |
Sale
|
March 25, 2019 |
$$1,001 - $15,000 |
April 15, 2019 |
|
Dean Phillips
|
house |
alexion Pharmaceuticals, Inc. (aLXN) |
ALXN |
STOCK |
Purchase
|
Jan. 4, 2019 |
$$1,001 - $15,000 |
Feb. 18, 2019 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Nov. 10, 2017 |
$Over $50,000,000,000 |
Dec. 21, 2017 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Nov. 10, 2017 |
$Over $50,000,000,000 |
Dec. 21, 2017 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Nov. 6, 2017 |
$Over $50,000,000,000 |
Dec. 21, 2017 |
|
Michael T. McCaul
|
house |
ALXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Aug. 1, 2017 |
$$15,001-$50,000 |
Sept. 28, 2017 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
June 25, 2017 |
$$1,000-15,000 |
July 27, 2017 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
May 12, 2017 |
$$100,001-$250,000 |
June 15, 2017 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
May 8, 2017 |
$$1,000-$15,000 |
June 15, 2017 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
May 8, 2017 |
$$1,000-$15,000 |
June 15, 2017 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
May 8, 2017 |
$$1,000-$15,000 |
June 15, 2017 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
May 3, 2017 |
$$100,001-$250,000 |
June 15, 2017 |
|
James R. Langevin
|
house |
Alexion Pharmaceuticals, Inc. (ALXN) |
ALXN |
STOCK |
Purchase
|
Jan. 6, 2017 |
$$15,001 - $50,000 |
Jan. 13, 2017 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Nov. 22, 2016 |
$$15,001-50,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Nov. 19, 2016 |
$$1,000,001-5,000,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Nov. 19, 2016 |
$$50,001-100,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Nov. 17, 2016 |
$$1,000-$15,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Oct. 4, 2016 |
$$1,000-$15,000 |
Nov. 17, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Oct. 4, 2016 |
$$15,001-$50,000 |
Nov. 17, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Oct. 2, 2016 |
$$1,000-15,000 |
Nov. 17, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
Purchase
|
Sept. 30, 2016 |
$$15,001-$50,000 |
Oct. 14, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
Purchase
|
Sept. 29, 2016 |
$$15,001-$50,000 |
Oct. 14, 2016 |